Sun, J <br/><br/>
Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Aug 2011 
 - 424-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2011.04750.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Adolescent<br/>Adult<br/>Aged<br/>Antiviral Agents--therapeutic use<br/>China<br/>Drug Resistance, Viral--drug effects<br/>Drug Therapy, Combination<br/>Female<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Lamivudine--therapeutic use<br/>Male<br/>Middle Aged<br/>Organophosphonates--therapeutic use<br/>Polyethylene Glycols--therapeutic use<br/>Recombinant Proteins<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult